Prepare to include a slide presentation if you are invited to submit a full proposal, as this is now a required application document. Additionally, the foundation has updated its contact information, directing general program inquiries to a new IBD Ventures email address.
Funder: Crohn's and Colitis Foundation
Due Dates: May 31, 2026 (Letter of Intent) | August 14, 2026 (Full Proposal, by invitation)
Funding Amounts: Up to $450,000 for one year; potential for renewal with an additional $450,000 if milestones are met.
Summary: Funds companies developing non-surgical, translational therapies targeting fibrotic complications in IBD, especially fibrostenosis.
Key Information: LOI required; full proposals accepted by invitation only.